October 2026 · 7 min read
HPLC and LC-MS in peptide testing: what each method can actually see
A summary of published research, with citations. It states no amount, schedule or route, and makes no claim about what this compound does in a person. Supplied for laboratory research use only.
Two questions get asked of a peptide sample, and they are not the same question.
How much of this material is the main component? That is a separation problem, and high-performance liquid chromatography answers it.
Is the main component the molecule it is supposed to be? That is an identification problem, and chromatography cannot answer it at all. Mass spectrometry can.
Almost every argument about peptide analysis is really an argument about which of those two questions a given report answered. Knowing where each method goes blind is the whole of reading one competently.
What HPLC measures
In reverse-phase HPLC, the sample is pushed through a column packed with a hydrophobic stationary phase while the solvent composition is changed over time — the gradient. Components that bind the stationary phase more strongly come off later. The detector, usually ultraviolet absorbance in the low 200-nanometre region where the peptide backbone absorbs, records a trace of signal against time.
The purity figure is derived from that trace: the area under the main peak as a percentage of the total area of all detected peaks. Two things about that definition do real work.
First, it is a relative measure. It describes the proportions of the things the detector saw, not the proportion of the vial's mass that is peptide. A sample can be 99% of detected area and still contain a great deal of salt and water, because neither registers.
Second, it depends entirely on the separation. Two components that leave the column at the same time are one peak, and one peak reports as one component.
Where HPLC goes blind
Co-elution. The impurities most likely to co-elute with a peptide are the ones most structurally similar to it: a single-residue deletion, an epimerised residue, a deamidated variant. These are exactly the impurities worth detecting, and they are the hardest to separate. A shallow, well-developed gradient resolves many of them; a short, steep one hides them.
Detector-invisible material. Counter-ions, inorganic salts, water, residual scavengers and bacterial endotoxin do not absorb meaningfully at the detection wavelength. None of them appear in the figure, and endotoxin in particular can dominate a biological result while leaving an immaculate chromatogram.
Identity, entirely. A UV trace records retention time and area. Two different peptides of similar hydrophobicity can produce closely similar traces. Chromatographic purity with no identity test is a measurement of how uniform the contents are, not of what they are.
This is why a single number, detached from its trace, is the least useful form a result can take. The trace shows where impurities sit, whether the peak is symmetrical, whether it is tailing or fronting, and whether the baseline was clean. The number shows none of it.
What mass spectrometry adds
A mass spectrometer ionises the sample and measures mass-to-charge ratio. For a peptide, that yields the molecular weight — and molecular weight is a strong identity constraint, because the intended sequence has exactly one.
It also resolves modifications that chromatography can only hint at, because each has a characteristic mass shift:
| Modification | Mass change | Why it matters |
|---|---|---|
| Deamidation of asparagine or glutamine | about +1 Da | A different molecule with nearly identical chromatographic behaviour |
| Oxidation of methionine | about +16 Da | The commonest storage degradation route for sequences containing it |
| Loss of water, or cyclisation | about −18 Da | Points to a specific degradation pathway rather than to impurity in general |
| Truncation by one residue | the residue's mass | Distinguishes incomplete synthesis from anything else |
What mass spectrometry does not resolve is anything that leaves the mass unchanged. D- and L-amino acid substitutions are mass-identical. So is a scrambled disulfide pairing, and so is any rearrangement that conserves atoms. Mass confirms composition; it does not confirm structure.
Why coupling the two matters
A separate HPLC run and a separate mass measurement give you a purity figure and a molecular weight, with no link between them. The mass could belong to the main peak or to anything else in the vial.
LC-MS puts the mass spectrometer at the outlet of the column, so every peak gets its own mass. That is a different quality of evidence: it confirms the main peak is the intended sequence, and it assigns an identity to the impurities. An impurity with a mass one residue short of the target is a synthesis problem. One with a mass 16 Da high is a storage problem. One you cannot name is a question mark, and knowing which of the three you have is often more useful than the purity figure itself.
For sequence confirmation rather than mass confirmation, tandem mass spectrometry fragments the peptide and reads the fragment masses, which maps the order of residues. This is standard in protein chemistry and uncommon on research-chemical reports.
What a complete report shows
Beyond the result, a method is reproducible only if it is described.
- Column chemistry, dimensions and particle size
- Mobile phases and the gradient programme, with run time
- Detection wavelength
- Injection volume and sample concentration
- System suitability: that the instrument was shown to be performing before the sample ran
- The chromatogram itself, with the integration visible
- For the mass data: ionisation mode, observed and theoretical masses, and the charge states
Validation vocabulary is worth knowing by name, because a report judged against a published standard is making a checkable claim. The United States Pharmacopeia and the European Pharmacopoeia both carry general chapters on chromatography; the International Council for Harmonisation publishes the analytical-validation guideline that most of this field is written against. Specificity, linearity, accuracy, precision, and limits of detection and quantitation are the parameters those documents define, and they are the vocabulary a competent laboratory will use without being asked.
How this bears on buying
The practical conclusion is narrow. A purity figure with no chromatogram is a claim you cannot audit. A chromatogram with no mass data establishes uniformity and not identity. An identity confirmation not coupled to the separation establishes that the intended molecule is present somewhere in the vial.
What to look for is both methods, on the same lot, from a named third-party laboratory, with the raw outputs attached. The broader question of what the resulting document does and does not cover is in what a certificate of analysis establishes; what happens to a correctly analysed peptide afterwards is in lyophilised peptides and what degrades them and in handling research peptides in the laboratory.
NovaEvum publishes a third-party report for each lot it sells. Janoshik-verified by HPLC with mass-spec identity confirmation; 100% synthetic. The measured purity for each lot is stated on its product page. Nothing here is medical, dosing, or therapeutic guidance.
Common questions
Is LC-MS strictly better than HPLC? It answers a question HPLC cannot, but it does not replace it. Quantitative purity is still a chromatographic measurement, and mass spectrometric response varies enormously between compounds, so a mass spectrometer is a poor instrument for measuring how much. The two are complementary, and a report with only one of them has a named blind spot rather than a general weakness.
Can a report be technically correct and still misleading? Yes, and the commonest route is a gradient too steep to resolve closely related impurities. The purity figure is then arithmetically right and biologically uninformative. This is the argument for reading the trace rather than the number.
Does HPLC tell me how much peptide is in the vial? No. That is peptide content, a separate determination against a reference — amino acid analysis and nitrogen determination are the usual approaches. A lyophilised solid is peptide plus counter-ions plus residual water, and chromatographic purity is silent about all three.
What cannot be detected by either method? Stereochemistry, disulfide scrambling, and bacterial endotoxin. The first two need orthogonal structural methods; endotoxin needs its own assay and is the one most worth asking about for any work in a living system.
All products sold by NovaEvum are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.